Times Online - AstraZeneca , the Anglo-Swedish drugs group, said that the European Patent Office has revoked its patent on Symbicort, its inhaled asthma treatment, which generated sales of $1.18 billion last year, including $1.02 billion in Europe. GlaxoSmithKline ...
